Oxford Asset Management »

Springworks Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $795k 17k 46.99
2025-03-31 $337k 7.6k 44.13
2020-03-31 $253k 9.4k 27.04
2019-12-31 $4.0M 104k 38.49
2019-09-30 $3.7M 168k 21.68

More positions owned by Oxford Asset Management

Spdr Series Trust S&p Biotech (XBI)
Snap Note 0.125% 3/0
Freeport-mcmoran CL B (FCX)
Dropbox Note 3/0
General Mills (GIS)
Ford Motor Company (F)
Comcast Corp Cl A (CMCSA)
Citigroup Com New (C)
Ferguson Enterprises Common Stock New (FERG)
Nike CL B (NKE)
Amazon (AMZN)
Boeing Company (BA)
EOG Resources (EOG)
Pfizer (PFE)
Meridianlink Common Stock (MLNK)

View all positions for Oxford Asset Management

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Sanctuary Advisors
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics